|1.||Kirsch, Andrew J: 10 articles (08/2014 - 07/2003)|
|2.||Scherz, Hal C: 9 articles (04/2009 - 07/2003)|
|3.||Canning, Douglas A: 4 articles (05/2014 - 04/2003)|
|4.||Puri, Prem: 4 articles (10/2007 - 10/2003)|
|5.||Kajbafzadeh, Abdol-Mohammad: 3 articles (02/2013 - 09/2012)|
|6.||Tourchi, Ali: 3 articles (02/2013 - 09/2012)|
|7.||Cerwinka, Wolfgang H: 3 articles (04/2009 - 10/2007)|
|8.||Colhoun, Eric: 3 articles (10/2007 - 10/2003)|
|9.||Mohanan, Nochiparambil: 3 articles (10/2007 - 10/2006)|
|10.||Caione, Paolo: 3 articles (10/2002 - 02/2002)|
|1.||Vesico-Ureteral Reflux (Vesicoureteral Reflux)
10/01/2003 - "Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney."
10/01/2002 - "In an open label study we investigated the effect of voiding dysfunction on the efficacy of endoscopic treatment with dextranomer/hyaluronic acid copolymer in patients with vesicoureteral reflux. "
10/01/2008 - "Injecting dextranomer/hyaluronic acid copolymer has gained popularity as first line treatment for vesicoureteral reflux. "
10/01/2006 - "To examine the outcomes of renal ultrasound studies after subureteral injection of dextranomer/hyaluronic acid copolymer and provide recommendations for postoperative management of vesicoureteral reflux (VUR). "
10/01/2006 - "Renal ultrasound studies after endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux."
10/01/2005 - "Alternative uses of dextranomer/hyaluronic acid copolymer: the efficacy of bladder neck injection for urinary incontinence."
10/01/2002 - "Patients with urinary incontinence due to neurogenic and structural causes were given a transurethral injection of dextranomer/hyaluronic acid copolymer to increase bladder outlet resistance. "
10/01/2002 - "Endoscopic treatment of urinary incontinence in pediatric patients: 2-year experience with dextranomer/hyaluronic acid copolymer."
10/01/2002 - "We investigated the effectiveness of dextranomer/hyaluronic acid copolymer (dextranomer microspheres in sodium hyaluronan solution) as a treatment for urinary incontinence due to sphincter incompetence in children and adolescents. "
|3.||Chronic Kidney Failure (Chronic Renal Failure)
05/01/2014 - "Aim of this study is to examine the effectiveness of dextranomer/hyaluronic acid copolymer and polyacrylate polyalcohol copolymer in endoscopic treatment of vesicoureteral reflux disease in adult patients with and without chronic renal failure. "
05/01/2011 - "To evaluate the outcome of subureteral injections by using calcium hydroxyapatite (CaHa), dextranomer/hyaluronic acid copolymer (Dx/HA), and polydimethylsiloxane (PDS) in patients with end-stage renal failure (ESRF) who have vesicoureteral reflux (VUR). "
06/01/2015 - "A consecutive series of patients with velopharyngeal insufficiency treated with dextranomer/hyaluronic acid copolymer were included in this study. "
06/01/2015 - "We studied the imaging appearance of dextranomer/hyaluronic acid copolymer implants in patients treated for velopharyngeal insufficiency. "
06/01/2015 - "Dextranomer/hyaluronic acid copolymer implants are used in treating velopharyngeal insufficiency. "
06/01/2015 - "Imaging appearance of dextranomer/hyaluronic acid copolymer implant injections for treatment of velopharyngeal insufficiency."
01/01/2012 - "The aim of this study is to present two cases of clinically significant complications following the use of dextranomer/hyaluronic acid copolymer, which led to the progression of the reflux degree, permanent infection of the urinary tract, and the necessity to perform surgical treatment. "
|2.||Hyaluronic Acid (Hyaluronan)